Hypertrophic cardiomyopathy (HCM) is congenital heart disease with prevalence 1 per 500. There are still unclear issues regarding optimal surgical strategy despite more than 50-year research of this disease. It is presented case report of surgical treatment of patient with obstructive HCM by using of non-standard volume and method of intervention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/hirurgia201905164 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of Mild or Moderate Calcific Aortic Valve Disease in Patients Undergoing Operation for Subaortic Obstruction.
Ann Thorac Surg
December 2024
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Background: This study sought to evaluate short- and long-term outcomes of aortic valve (AV) intervention by decalcification or replacement for the treatment of mild to moderate calcific AV stenosis (AS) in patients undergoing transaortic septal myectomy for subaortic left ventricular outflow tract (LVOT) obstruction.
Methods: Between 2000 and 2023, study investigators identified 137 consecutive patients undergoing myectomy with or without membranectomy for mild to moderate calcific AS. Of these patients, 93 underwent surgical intervention on the AV and formed the primary cohort; 44 patients who did not undergo AV intervention were used as a control group.
Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the study.
Kardiochir Torakochirurgia Pol
September 2024
Division of Cardiac Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy.
Introduction: The Perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative complications.
Aim: To evaluate early hemodynamic performance and immediate outcomes of implantation of the Perceval sutureless bioprosthesis in comparison with the St. Jude Trifecta sutured bioprosthesis for aortic valve replacement (Perfecta study).
Multicenter, propensity-weighted comparison of stented, rapid-deployment and new-generation aortic valves.
Int J Cardiol Heart Vasc
October 2024
Division of Cardiac Surgery, University of Padova, Padova, Italy.
Article Synopsis
- The study compares early clinical and hemodynamic outcomes of three types of bioprosthetic valves used in surgical aortic valve replacement: Magna Ease, Intuity, and Inspiris Resilia.
- Data from 2589 patients revealed that the Intuity valve had the shortest aortic cross clamp time, while Inspiris showed the lowest permanent pace-maker implantation rates.
- All devices demonstrated excellent outcomes, but Inspiris had the best overall performance with lower gradient measurements compared to the Magna Ease valve.
Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: Findings from the CAMPOS-TAVI study.
Arch Cardiovasc Dis
September 2024
Cardiology Department, University Hospital of Reims, rue du Général-Koenig, 51100 Reims, France.
Article Synopsis
- Transthyretin amyloid cardiomyopathy (ATTR-CM) can complicate conditions like heart failure and aortic stenosis (AS), especially in older adults, but its prevalence among AS patients undergoing transaortic valve implantation (TAVI) is not well-studied.
- A study screening 100 TAVI patients showed an ATTR-CM prevalence of 7%, predominantly in older males, with specific electrocardiographic and structural heart changes noted in those positive for ATTR-CM.
- One-year survival rates for patients with positive ATTR-CM tests were similar to those with isolated AS, emphasizing the need for ongoing monitoring and further research on long-term outcomes in ATTR-CM patients post-TAVI.
Novel Techniques and Technologies for Surgical Aortic Valve Replacement: A Large Retrospective Cohort Analysis.
J Clin Med
July 2024
Cardiovascular Department, St. Thomas' Hospital, London SE1 7EH, UK.
: In an era of growing evidence for transaortic valve implantation (TAVI), our research topic was the evaluation of how surgical aortic valve replacements (SAVRs) are performing in terms of short- and long-term outcomes in different risk categories. : This was a single centre, prospective, and observational cohort study of consecutive patients with aortic valve stenosis, undergoing isolated aortic valve replacement using a biological or mechanical prosthesis, Freestyle™ (Medtronic, Minneapolis, MN, USA) graft, homograft, or Ross procedure. The participant data were collected by review of an internal database.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!